ResearcherEmory UniversityActive in the last 2 years

Sarwish Rafiq

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9295-3065; OpenAlex author ID A5057969753. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer. Last author DOI 10.1016/j.omton.2024.200868 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Heather K. Lin · 1 shared paper, 2024 · strength 0.24
- Paper Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer. DOI 10.1016/j.omton.2024.200868 ↗
Gregory B. Lesinski · 1 shared paper, 2024 · strength 0.24
- Paper Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer. DOI 10.1016/j.omton.2024.200868 ↗
Lily Yang · 1 shared paper, 2024 · strength 0.24
- Paper Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer. DOI 10.1016/j.omton.2024.200868 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.